A detailed history of Wolverine Asset Management LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Wolverine Asset Management LLC holds 4,300 shares of NEO stock, worth $58,007. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,300
Previous 8,700 50.57%
Holding current value
$58,007
Previous $128,000 45.31%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$13.0 - $18.43 $14,729 - $20,881
1,133 New
1,133 $18,000
Q2 2022

Aug 03, 2022

SELL
$7.06 - $13.97 $1.01 Million - $1.99 Million
-142,763 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$12.15 - $35.28 $1.73 Million - $5.04 Million
142,763 New
142,763 $1.73 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.7B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.